UBE2C and esophageal squamous cell carcinoma: In addition, by analyzing the relapse-free survival (RFS) of UBE2C in the ESCC dataset, we found that ESCC patients with high expression of UBE2C tended to have a lower risk of recurrence, and the p value was not statistically significant (Fig. 6d-e).